INNPF Stock Innocan Pharma (INNPF, $21.1) RSI Indicator left the oversold zone on December 04, 2024

GET DAILY SIGNALS

Get AI intraday signals

INNPF - Innocan Pharma Corp.

RSI signal

View

Odds of UP Trend

Price: $21.1

Daily change: +$20.9433 (+13,365%)

Daily volume: 2.9K

Capitalization: $43.9M

Industry: Pharmaceuticals: Other

INNPF in -3.66% downward trend, sliding for three consecutive days on December 18, 2024

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where INNPF declined for three days, in of 57 cases, the price declined further within the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on December 18, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on INNPF as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INNPF's RSI Oscillator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INNPF just turned positive on December 12, 2024. Looking at past instances where INNPF's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

INNPF moved above its 50-day moving average on December 10, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for INNPF crossed bullishly above the 50-day moving average on December 17, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +13,80 3-day Advance, the price is estimated to grow further. Considering data from situations where INNPF advanced for three days, in of 56 cases, the price rose further within the following month. The odds of a continued upward trend are .

INNPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 62 cases where INNPF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.406) is normal, around the industry mean (57.958). P/E Ratio (0.000) is within average values for comparable stocks, (89.727). INNPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.074) settles around the average of (0.122) among similar stocks. INNPF's P/S Ratio (208.333) is very high in comparison to the industry average of (19.472).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INNPF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INNPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.